DK1667665T3 - Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler - Google Patents

Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler

Info

Publication number
DK1667665T3
DK1667665T3 DK04764591T DK04764591T DK1667665T3 DK 1667665 T3 DK1667665 T3 DK 1667665T3 DK 04764591 T DK04764591 T DK 04764591T DK 04764591 T DK04764591 T DK 04764591T DK 1667665 T3 DK1667665 T3 DK 1667665T3
Authority
DK
Denmark
Prior art keywords
active substance
different
active substances
substance pellets
release profiles
Prior art date
Application number
DK04764591T
Other languages
English (en)
Inventor
Sergej Anschuetz
Roland Schneider
Original Assignee
Pharmaton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaton Sa filed Critical Pharmaton Sa
Application granted granted Critical
Publication of DK1667665T3 publication Critical patent/DK1667665T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK04764591T 2003-09-03 2004-08-28 Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler DK1667665T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03019577 2003-09-03
PCT/EP2004/009617 WO2005023229A1 (de) 2003-09-03 2004-08-28 Kapsel enthaltend wirkstoffpellets mit unterschiedlichen freisetzungsprofilen

Publications (1)

Publication Number Publication Date
DK1667665T3 true DK1667665T3 (da) 2009-05-04

Family

ID=34259144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04764591T DK1667665T3 (da) 2003-09-03 2004-08-28 Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler

Country Status (17)

Country Link
US (1) US20050058704A1 (da)
EP (1) EP1667665B1 (da)
JP (1) JP4897483B2 (da)
AT (1) ATE419841T1 (da)
BR (1) BRPI0413201A (da)
CA (1) CA2537477C (da)
CY (1) CY1108950T1 (da)
DE (1) DE502004008834D1 (da)
DK (1) DK1667665T3 (da)
ES (1) ES2317024T3 (da)
MX (1) MXPA06002316A (da)
PL (1) PL1667665T3 (da)
PT (1) PT1667665E (da)
RU (1) RU2356540C2 (da)
SI (1) SI1667665T1 (da)
UA (1) UA87471C2 (da)
WO (1) WO2005023229A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
EP1689373B1 (en) * 2003-10-10 2019-04-03 Ethypharm Sustained-release microgranules containing ginkgo biloba extract and the process for manufacturing these
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
DE102006006532B4 (de) 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
CN101453996B (zh) * 2006-04-03 2016-05-11 伊萨·奥迪迪 药物递送组合物
CA2677623C (en) * 2007-02-09 2015-04-07 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
KR20100015526A (ko) * 2007-03-12 2010-02-12 피펙스 파마슈티컬스, 인코포레이티드 유리 구리 흡수 및 유리 구리 수준을 안전하게 낮추는데 유용한 경구용 아연 의약
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) * 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP2229155A4 (en) * 2007-12-12 2010-12-29 Northern Innovations And Formulations Corp Particles in a capsule
CN102098921A (zh) 2008-05-19 2011-06-15 温顿制药有限公司 高载量、控释镁口服制剂及其制备和使用方法
WO2010010579A1 (en) * 2008-07-19 2010-01-28 Lupin Limited Multiple unit dosage form of niacin
US20130011469A1 (en) 2009-07-23 2013-01-10 U.S. Nutraceuticals, Llc D/B/A Valensa International Krill oil and carotenoid composition, associated method and delivery system
CN102038691B (zh) * 2009-10-12 2014-06-11 杭州赛利药物研究所有限公司 一种维生素氨基酸的复合制剂及其制备方法
DE102010022174A1 (de) * 2010-05-12 2011-11-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol
WO2014071176A1 (en) * 2012-11-02 2014-05-08 Disilvestro Robert Nutritional supplements including meal replacements and related methods
US20150104539A1 (en) * 2013-10-15 2015-04-16 Via Naturally, LLC Citrated folic acid compositions and methods for delivering folic acid to usp dissolution specifications
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
US20190201350A1 (en) * 2016-08-15 2019-07-04 Corr-Jensen Inc. Time release of fat-soluble actives
ES2695503B2 (es) * 2017-06-30 2020-05-08 Pharmalink S L Formulaciones encapsuladas
KR102368654B1 (ko) * 2020-04-17 2022-02-28 주식회사 청안오가닉스 녹차 카테킨을 포함하는 경구용 캡슐
KR20230038225A (ko) * 2020-07-09 2023-03-17 디에스엠 아이피 어셋츠 비.브이. 장내 마이크로바이옴에서 코프로코커스 종의 개체수 증가 방법
CN111821266B (zh) * 2020-07-17 2021-09-14 迪沙药业集团有限公司 一种牛磺酸缓释组合物及其制备方法
WO2026039789A1 (en) * 2024-08-16 2026-02-19 Golpanian Pejman Therapeutic composition for mitigating post-surgical inflammation, scarring and risk of infection and method of administering same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50151874A (da) * 1974-05-16 1975-12-06
JPS50151874U (da) * 1974-06-01 1975-12-17
JPS5347513A (en) * 1976-10-14 1978-04-28 Meiji Seika Kaisha Ltd Preparation of enzymatic agent
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
JPS5982311A (ja) * 1982-11-04 1984-05-12 Shionogi & Co Ltd セフアレキシン持効性製剤
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
RU2128499C1 (ru) * 1992-12-23 1999-04-10 Сайтек С.Р.Л. Способ получения фармацевтических форм с контролированным высвобождением действующего вещества и формы, полученные данным способом
FR2705233B1 (fr) * 1993-05-14 1996-07-12 Atheliapharm Sa Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique.
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
IT1283478B1 (it) * 1996-07-22 1998-04-21 Roberto Valducci Composizioni per integrazione nutrizionale comprendenti vitamine idrosolubili a rilascio prolungato
EP0886519A1 (en) * 1996-11-01 1998-12-30 Ilex Oncology, Inc. Sustained release formulation containing dfmo
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
CN1161112C (zh) * 1999-02-23 2004-08-11 株式会社柳韩洋行 含氯雷他定和伪麻黄碱的药物胶囊组合物
WO2000069420A1 (en) * 1999-05-14 2000-11-23 Coraltis Ltd. Pulse-delivery oral compositions
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements

Also Published As

Publication number Publication date
WO2005023229A1 (de) 2005-03-17
JP4897483B2 (ja) 2012-03-14
RU2006110549A (ru) 2007-10-10
PT1667665E (pt) 2009-02-13
CA2537477C (en) 2013-05-14
US20050058704A1 (en) 2005-03-17
CY1108950T1 (el) 2014-07-02
MXPA06002316A (es) 2006-05-19
SI1667665T1 (sl) 2009-06-30
RU2356540C2 (ru) 2009-05-27
ES2317024T3 (es) 2009-04-16
PL1667665T3 (pl) 2009-06-30
JP2007504189A (ja) 2007-03-01
DE502004008834D1 (de) 2009-02-26
EP1667665B1 (de) 2009-01-07
EP1667665A1 (de) 2006-06-14
ATE419841T1 (de) 2009-01-15
BRPI0413201A (pt) 2006-10-03
CA2537477A1 (en) 2005-03-17
UA87471C2 (uk) 2009-07-27

Similar Documents

Publication Publication Date Title
CY1108950T1 (el) Καψουλες που περιεχουν σφαιριδια δραστικης ουσιας με διαφορετικα προφιλ απελευθερωσης
WO2007067044A3 (en) Modified active-ingredient-containing pellets/capsules
IL190646A (en) Multi-functional ionic liquid compositions comprising active pharmaceutical, biological, nutritional and energetic ingredients and method for producing the same
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
EA200970374A1 (ru) Лечение антиаритмическими средствами и омега-3 жирными кислотами и их комбинированным продуктом
WO2006105306A3 (en) Compostions containing fatty acids and/or derivatives thereof and a low temperature stabilizer
UA86595C2 (ru) Гамма-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит
WO2011116139A3 (en) Improved pharmaceutical compositions comprising cck- 8 and methods of delivery
WO2003043631A3 (en) Method for identification of tumor targeting enzymes
SG162773A1 (en) Flavonoid compounds and uses thereof
WO2001089571A3 (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
DK1906928T3 (da) Kerner og mikrokapsler egnet til parenteral administration og fremgangsmåder til fremstilling deraf
WO2008011538A3 (en) Methods of using flavonoids to enhance memory
EP2233504A4 (en) A ERYTHROPOIETIN MIMETIC PEPTIDE DERIVATIVE AND ITS PHARMACEUTICAL SALT, ITS PREPARATION AND ITS APPLICATIONS
IS6511A (is) Lyfjaefnablöndur sem innihalda sykurfitusýru estera til að stýra losun á virkum innihaldsefnum
WO2006137069A3 (en) Balanites aegyptiaca saponins and uses thereof
NO20052683D0 (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
EP1961764A4 (en) SUGAR CHAIN ADDUCT OF A PEPTIDE AND PHARMACEUTICAL THAT CONTAINS THIS AS AN ACTIVE SUBSTANCE
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
BRPI0620229A8 (pt) formulação
BR0309851A (pt) Processos e formulações para aperfeiçoamento de absorção e biodisponibilidade gastrointestinal de drogas hidrofóbicas
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete